tiprankstipranks
Trending News
More News >
Mannkind Corp. (MNKD)
NASDAQ:MNKD
US Market
Advertisement

MannKind (MNKD) Drug Pipeline

Compare
1,943 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
(Part A) Mknd-201, (Part B) Mknd-201
Healthy Volunteers
Phase I
Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers
Jul 26, 2024
Clofazimine Inhalation Suspension
Mac Lung Disease, Treatment Refractory Mac Lung Disease, Mycobacterium Infections, Nontuberculous
Phase III
Recruiting
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
May 08, 2024
Insulin Degludec, Basal Insulin, Afrezza, Rapid-Acting Insulin Analog
Diabetes Mellitus, Type 1
Phase IV
Completed
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
Jun 02, 2023
Insulin Degludec, Afrezza (Insulin Human) Inhalation Powder, Continuous Subcutaneous Insulin Infusion (Csii) Pump With Automatic Insulin Delivery (Aid)
Type 1 Diabetes
Phase IV
Completed
Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes
Feb 07, 2022
Basal Insulin, Afrezza, Rapid-Acting Insulin Analog
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Phase III
Completed
Afrezza® INHALE-1 Study in Pediatrics
Jun 22, 2021
Afrezza Dose 1, Afrezza Dose 2
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Phase IV
Completed
Afrezza® Dosing Optimization Study
Apr 16, 2021
Afrezza Inhalant Product
Type 2 Diabetes Treated With Insulin
Phase IV
Unknown
A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily Injections
Oct 09, 2019
Treprostinil Inhalation Powder
Pulmonary Arterial Hypertension
Phase I
Completed
Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
Mar 01, 2018
Afrezza Plus One Drop | Premium, One Drop | Premium
Diabetes Mellitus, Type 2
Phase IV
Unknown
A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone
Oct 10, 2017
Afrezza
Type 1 Diabetes Mellitus
Phase II
Completed
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Aug 17, 2015

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Mannkind Corp. (MNKD) have in its pipeline
      MNKD is currently developing the following drugs: (Part A) Mknd-201, (Part B) Mknd-201, Clofazimine Inhalation Suspension, Insulin Degludec, Basal Insulin, Afrezza, Rapid-Acting Insulin Analog. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis